Home Other Building Blocks 6-Aminoquinazoline

6-Aminoquinazoline

CAS No.:
101421-72-1
Catalog Number:
AG0004GP
Molecular Formula:
C8H7N3
Molecular Weight:
145.1613
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
100mg
98%
In Stock USA
United States
$75
- +
250mg
98%
In Stock USA
United States
$94
- +
1g
98%
In Stock USA
United States
$219
- +
5g
98%
In Stock USA
United States
$688
- +
Product Description
Catalog Number:
AG0004GP
Chemical Name:
6-Aminoquinazoline
CAS Number:
101421-72-1
Molecular Formula:
C8H7N3
Molecular Weight:
145.1613
MDL Number:
MFCD10697883
IUPAC Name:
quinazolin-6-amine
InChI:
InChI=1S/C8H7N3/c9-7-1-2-8-6(3-7)4-10-5-11-8/h1-5H,9H2
InChI Key:
XFGPXURFKAUHQR-UHFFFAOYSA-N
SMILES:
Nc1ccc2c(c1)cncn2
Properties
Complexity:
137  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
145.064g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
145.165g/mol
Monoisotopic Mass:
145.064g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
51.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.3  
Literature
Title Journal
Specific PKC isoforms regulate LPS-stimulated iNOS induction in murine microglial cells. Journal of neuroinflammation 20110101
Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy. PloS one 20110101
Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae. PloS one 20100101
The combi-targeting concept: evidence for the formation of a novel inhibitor in vivo. Anti-cancer drugs 20060201
Fluorescence and analytical ultracentrifugation analyses of the interaction of the tyrosine kinase inhibitor, tyrphostin AG 1478-mesylate, with albumin. Analytical biochemistry 20050715
A novel structural class of potent inhibitors of NF-kappa B activation: structure-activity relationships and biological effects of 6-aminoquinazoline derivatives. Bioorganic & medicinal chemistry 20030901
Properties